Pharmacologic Therapies for Obesity: The Future is Here

Join us in this expert podcast as we delve into the captivating world of GLP-1 receptor agonists (GLP-1RAs), exploring their profound impact on weight management and cardiometabolic effects. We also discuss the potential cardiovascular benefits affecting patients with obesity and cardiovascular disease.

Connect with Mayo Clinic’s Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter https://www.twitter.com/mayocliniccv and https://twitter.com/MayoCVservices

LinkedIn: https://www.linkedin.com/company/mayo-clinic-cardiovascular-services

Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple App Store: https://apps.apple.com/us/app/mayo-clinic-cardiovascular-cme/id1578924841 or Google Play store: https://play.google.com/store/apps/details?id=org.mayoclinic.cvcme today!

No CME credit offered for this episode.